Europe — EMA

Paclitaxel Accord

Paclitaxel, the active ingredient in Paclitaxel Accord, is a taxane presented as a strength/form for intravenous use. It treats various solid tumours and is administered in oncology patients.

Paclitaxel

Request sourcing

Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Paclitaxel Accord, is a taxane presented as a strength/form for intravenous use. It treats various solid tumours and is administered in oncology patients. GNH USA supplies Paclitaxel Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

GNH USA supplies Paclitaxel Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and oncology centres worldwide.

What is Paclitaxel used for?

Paclitaxel is a chemotherapeutic agent that interferes with the cell growth pathway of solid tumours and offers clinical benefits in several oncologic indications.

- Breast breast cancer : Provides clinical benefit by stabilising micro‑tubules and inhibiting cell division . - Ovarian ov ovarian : Hel .... - Non‑ .... - ... ... ... . - .... .... . - ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →